Short- and long-term effects of imatinib in patients hospitalised for COVID-19: A randomised trial
Alex L E Halme(University of Helsinki), Kari A.O. Tikkinen(Helsinki University Hospital), Marjatta Sinisalo(Tampere University Hospital), Hanna Ansakorpi(Oulu University Hospital), Aija Vanhanen(Peijas Hospital), Olli Nevalainen(Finnish Meteorological Institute), Pauliina Kuutti(University of Helsinki), Tuomas Rosberg(University of Helsinki), Tuomas P. Kilpeläinen(University of Helsinki), Saana Horstia(University of Helsinki), Heikki Kauma(University of Oulu), Thijs Feuth(Turku University Hospital), Andreas Renner(University of Helsinki), Juuso Paajanen(Brigham and Women's Hospital), Seppo Parkkila(Tampere University), Sanna Laakkonen(University of Helsinki), Jarkko Mäntylä(University of Helsinki), Erja‐Leena Paukkeri(University of Helsinki), Jussi Mustonen(Valmet Automotive (Finland)), Ilkka Kalliala(Imperial College London), Maarit K. Leinonen(University of Helsinki), Hanna‐Riikka Kreivi(University of Helsinki), Taina Nykänen(Turku University Hospital), Ilari Kuitunen(University of Eastern Finland), Marjukka Myllärniemi(University of Helsinki), Petrus Järvinen(University of Helsinki), Markus Perola(Oulu University Hospital), Taina Hammarén(Herttoniemi Hospital), Alvar Külmäsu(Päijät-Hämeen Keskussairaala), Riikka Ala-Karvia(Seinäjoki University of Applied Sciences), Tiina Mattila(University of Helsinki), Riitta-Liisa Patovirta(University of Helsinki), Jarno Rutanen(Tampere University Hospital), Negar Pourjamal(University of Helsinki), Gordon Guyatt(McMaster University), Riina Hankkio(Tampere University Hospital)
Cited by 0
Related Papers
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
Sex-Related Differences in Autonomic Modulation of Heart Rate in Middle-aged Subjects
|Circulation|1996|446